• About us
  • Team
  • Privacy Policy
  • Contact
Sunday, November 22, 2026
  • Login
No Result
View All Result
World's first weekly chronicle of development news
  • Blitz Highlights
    • Special
    • Spotlight
    • Insight
    • Entertainment
    • Sports
  • Opinion
  • Legal
  • Perspective
  • Nation
    • East
    • West
    • North
    • South
  • Business & Economy
  • World
  • Hindi Edition
  • International Editions
    • Dubai
    • Tanzania
    • United Kingdom
    • USA
  • Blitz India Business
  • Blitz Highlights
    • Special
    • Spotlight
    • Insight
    • Entertainment
    • Sports
  • Opinion
  • Legal
  • Perspective
  • Nation
    • East
    • West
    • North
    • South
  • Business & Economy
  • World
  • Hindi Edition
  • International Editions
    • Dubai
    • Tanzania
    • United Kingdom
    • USA
  • Blitz India Business
No Result
View All Result
World's first weekly chronicle of development news
No Result
View All Result

Global Type 1 diabetes market to reach $9.9 billion by 2033

by Blitz India Media
January 2, 2025
in News
0
Global Type 1 diabetes market to reach $9.9 billion by 2033
Blitz Bureau

NEW DELHI: Global Type 1 diabetes market is set to grow at a compound annual growth rate (CAGR) of 13.3 per cent from $2.2 billion in 2023 to $9.9 billion in 2033, according to a report on December 2. The report by GlobalData, a data and analytics company, showed that the growth will be particularly in the seven major countries like the US, France, Germany, Italy, Spain, the UK, and Japan.

Among these countries, the US has the largest market, accounting for 80.4 per cent of global sales in 2023 ($2.2 billion). It is expected to gain further market share during the forecast period, accounting for 91.6 per cent of the seven countries for Type 1 diabetes sales by 2033 ($9.0 billion).

The growth in these countries is driven by the anticipated introduction of several late-stage pipeline products, including multiple immunomodulatory agents, during the forecast period, said the report.

“The increasing popularity of rapid-acting and ultra-rapid-acting insulin analogues in line with rising insulin pump use is expected to improve patient outcomes by optimising glycemic control,” said Sulayman Patel, Pharma Analyst at GlobalData.

Research shows “high volumes of prescribing physicians and patients have demonstrated positive attitudes towards the use of ultra-rapid insulin analogues, which is expected to drive Type 1 diabetes market growth.”

The late-stage Type 1 diabetes pipeline consists of several agents, including Eli Lilly’s insulin efsitora alfa, Novo Nordisk’s Awiqli (insulin codec), Johnson & Johnson’s ustekinumab, Dompe Pharmaceuticals’ ladarixin, and Diamyd Medical’s vaccine for Type 1 diabetes.

Sanofi’s Tzield (teplizumab) is the only approved disease-modifying therapy for Type 1 diabetes.
Tzield received FDA approval in November 2022 and is the first treatment for Type 1 diabetes that targets the underlying disease mechanisms by delaying the onset of stage 3 Type 1 diabetes in patients 8 years and older.
The report expects Tzield to gain European approval and become the top-selling drug in the Type 1 diabetes market with sales of $4.8 billion across the seven countries in 2033.

Related Posts

India and France Strengthen Counter-Terrorism Cooperation
News

India, France discuss ways to counter terror financing

November 20, 2026
Indian stock market
News

Sensex jumps 898 points, Nifty closes above 25,800

November 20, 2026
Jaiswal
News

Jaiswal’s 85, Rahul’s unbeaten fifty puts India in charge against New Zealand

November 20, 2026
EPFO
News

EPFO approves monthly pension-style withdrawl from PF corpus

November 20, 2026
India-Japan Defence Cooperation
News

India, Japan reaffirm commitment to free, open and rules-based Indo-Pacific

November 19, 2026
Indian stock market
News

Sensex jumps 990 points, Nifty reclaims 25,500 as auto stocks power rally

November 19, 2026
Load More
Next Post
gill

How Gill comes into the playing eleven, that’s the call of the team: Shastri

Recent News

India and France Strengthen Counter-Terrorism Cooperation
News

India, France discuss ways to counter terror financing

by Blitz India Media
November 20, 2026
0

Blitz Bureau New Delhi, 20 November: India and France held the 18th meeting of the Joint Working Group (JWG) on...

Read moreDetails
Indian stock market

Sensex jumps 898 points, Nifty closes above 25,800

November 20, 2026
Jaiswal

Jaiswal’s 85, Rahul’s unbeaten fifty puts India in charge against New Zealand

November 20, 2026
EPFO

EPFO approves monthly pension-style withdrawl from PF corpus

November 20, 2026
India-Japan Defence Cooperation

India, Japan reaffirm commitment to free, open and rules-based Indo-Pacific

November 19, 2026

Blitz Highlights

  • Special
  • Spotlight
  • Insight
  • Entertainment
  • Health

International Editions

  • US (New York)
  • UK (London)
  • Middle East (Dubai)
  • Tanzania (Africa)

Nation

  • East
  • West
  • South
  • North
  • Hindi Edition

E-paper

  • India
  • Hindi E-paper
  • Dubai E-Paper
  • USA E-Paper
  • UK-Epaper
  • Tanzania E-paper

Useful Links

  • About us
  • Team
  • Privacy Policy
  • Contact

©2024 Blitz India Media -Building A New Nation

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

    No Result
    View All Result
    • Blitz Highlights
      • Special
      • Spotlight
      • Insight
      • Entertainment
      • Sports
    • Opinion
    • Legal
    • Perspective
    • Nation
      • East
      • West
      • North
      • South
    • Business & Economy
    • World
    • Hindi Edition
    • International Editions
      • Dubai
      • Tanzania
      • United Kingdom
      • USA
    • Blitz India Business

    ©2024 Blitz India Media -Building A New Nation